Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myelin basic protein as a possible marker for oligodendroglioma.

J Tanaka1, Y Hokama, H Nakamura

  • 1Institute of Neurological Sciences, Tottori University School of Medicine, Yonago, Japan.

Acta Pathologica Japonica
|October 1, 1988
PubMed
Summary

Myelin basic protein (MBP) can serve as a marker for oligodendroglioma. Immunohistochemical analysis found MBP in some tumors, potentially indicating a myelin-forming glial phenotype in cancer cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Semidiscoid lateral meniscus].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

[Abnormal chest shadow on CT in immunosuppressed patients].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

[MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations.

Biochemistry·1992
Same author

Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene.

FEBS letters·1992
Same author

Inhibition of passive cutaneous anaphylaxis by synthetic human immunoglobulin E peptide fragments.

FEBS letters·1992

Area of Science:

  • Neuro-oncology
  • Immunohistochemistry
  • Molecular Pathology

Background:

  • Oligodendrogliomas are primary brain tumors arising from oligodendrocytes.
  • Accurate diagnosis and subtyping of oligodendrogliomas are crucial for prognosis and treatment.
  • Identifying specific cellular markers can aid in tumor classification.

Purpose of the Study:

  • To investigate the utility of myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) as immunohistochemical markers for oligodendroglioma.
  • To correlate the expression of MBP and GFAP with tumor grade and cellular morphology.

Main Methods:

  • Immunohistochemical analysis of MBP and GFAP was performed on 38 oligodendroglioma tissue samples.
  • Double immunostaining was utilized to assess co-expression of MBP and GFAP in tumor cells.

Related Experiment Videos

  • Tumor grading was based on the WHO classification system.

    • Main Results:

    • Myelin basic protein (MBP) was detected in 14 out of 38 oligodendrogliomas, primarily in poorly differentiated (WHO grade II) tumors.
    • MBP-positive cells exhibited characteristics resembling immature oligodendrocytes.
    • Glial fibrillary acidic protein (GFAP) was also found in some tumors, with some cells showing co-expression of both MBP and GFAP.
    • Mature (grade I) and anaplastic (grade III) oligodendroglioma cells were MBP-negative.

    Conclusions:

    • Myelin basic protein (MBP) shows promise as a specific marker for a subset of oligodendrogliomas, particularly those with features of immaturity.
    • Co-expression of MBP and GFAP suggests an intrinsic myelin-forming glial phenotype in some oligodendroglioma cells.
    • MBP immunohistochemistry can be a valuable tool in the diagnostic evaluation of oligodendroglioma.